NCT05189483 2024-02-07
Albumin-bound Paclitaxel Plus Camrelizumab for Advanced Soft Tissue Sarcoma.
Henan Cancer Hospital
Phase 2 Unknown
Clinical Trials
10 trialsNCT03296553 2022-01-27
Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.
National Institute of Cancerología
Phase 2 Completed
NCT03390946 2018-01-09
Feasibility Study of Interval Compressed Regimen Using Four-drugs for Osteosarcoma
National Cancer Center, Korea
Phase 2 Unknown
NCT02982486 2017-11-01
A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma
Assaf-Harofeh Medical Center
Phase 2 Unknown
NCT03163381 2017-05-23
Apatinib Second Line Treatment for Advanced Osteosarcoma and Soft Tissue Sarcomas ,Openting ,Single Center, One-armed Clinical Study.
Henan Cancer Hospital
Phase 2 Unknown
NCT01296815 2015-07-27
Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity
Centro de Investigación en. Enfermedades Infecciosas, Mexico
Phase 2 Completed
NCT01380275 2014-09-25
Trial of Docetaxel and Irinotecan (DI) for Recurrent or Refractory Bone and Soft Tissue Sarcomas.
National Cancer Center, Korea
Phase 2 Unknown
NCT01898416 2013-10-31
Safety and Efficacy Study Using 5-ALA Oral Administration as an Adjuvant Therapy on the Rate of Local Tumor Recurrence in Patients Who Have Desmoids Tumors
Tel-Aviv Sourasky Medical Center
Phase 2 Recruiting
NCT01412515 2012-01-02
A Phase II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation of Oral mTOR-inhibitor Everolimus (RAD001) 10 mg Daily in Patients Suffering From Classic or Endemic Kaposi's Sarcoma
Institut National de la Santé Et de la Recherche Médicale, France
Phase 2 Terminated
NCT00127569 2007-01-12
Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy
French National Agency for Research on AIDS and Viral Hepatitis
Phase 2 Terminated